` Comparison: BML vs PNEXF - Alpha Spread

B
BML
vs
PNEXF

Over the past 12 months, BML has underperformed PNEXF, delivering a return of 0% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BML
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

B
BML Intrinsic Value
Not Available
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
B
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
5.8 PLN
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BML, PNEXF

BML
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
Biomed Lublin Wytwornia Surowic i Szczepionek SA
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BML, PNEXF

BML
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BML
56.9%
PNEXF
0%

Operating Margin

BML
22%
PNEXF
-17 526.7%

Net Margin

BML
14.1%
PNEXF
-21 040%

FCF Margin

BML
-79.1%
PNEXF
-15 953.3%

ROE

BML
8.4%
PNEXF
114.6%

ROA

BML
5.1%
PNEXF
-391.1%

ROIC

BML
8%
PNEXF
3 092.9%

ROCE

BML
9.6%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BML, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BML, PNEXF

Loading
BML
PNEXF
Difference
www.alphaspread.com

Performance By Year
BML, PNEXF

Loading
BML
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BML to other stocks
ABBV
Abbvie Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
VRTX
Vertex Pharmaceuticals I...
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account